Autor: |
Chan, M.F., Okun, I., Stavros, F.L., Hwang, E., Wolff, M.E., Balaji, V.N. |
Zdroj: |
Biochemical and Biophysical Research Communications; May 30, 1994, Vol. 201 Issue: 1 p228-234, 7p |
Abstrakt: |
Novel endothelin antagonists were identified through a "pharmacophore directed screening" strategy. The sulfanilamide antibacterial agent sulfisoxazole was found to be a good endothelin receptor antagonist (IC50's of 0.60 µM and 22 µM for the ETA and ETB receptors, respectively). The structurally similar sulfamethoxazole was found to be a weaker antagonist (IC50 for ETA 16 µM and for ETB 230 µM). These compounds represent a new class of low molecular weight and ETA-selective non-peptide endothelin antagonists.Copyright 1994, 1999 Academic Press, Inc. |
Databáze: |
Supplemental Index |
Externí odkaz: |
|